CXApp Inc. Form 8-K Summary
Business context and reporting period
CXApp Inc. filed a Form 8-K on March 31, 2023, reporting events occurring on March 29, 2023. The filing concerns executive appointments and employment agreements, not quarterly or annual financial results.
Executive appointments and compensation
- Khurram P. Sheikh: Continued as Chief Executive Officer and serves as Chairman. His employment agreement provides for an annual salary of $325,000 and a target annual bonus of $325,000.
- Mr. Sheikh is expected to receive options to purchase 844,200 shares of Class A common stock, subject to approval by the board or compensation committee. The options are expected to have an exercise price equal to the market price on the grant date, a two-year term, and vest in equal installments over 24 months, subject to continued employment.
- Unvested options would fully accelerate upon a qualifying change in control.
- Leon Papkoff: Appointed Chief Product Officer effective March 29, 2023. His employment agreement provides for an annual salary of $300,000 and a target annual bonus of $150,000.
- Mr. Papkoff is expected to receive restricted stock units representing 295,000 shares of Class A common stock, subject to approval by the board or compensation committee and the applicable award agreement. Unvested RSUs would fully accelerate upon a qualifying change in control.
Financial metrics and liquidity
The filing does not provide revenue, profit, cash flow, margins, debt, liquidity, or other operating or balance-sheet metrics. It also does not provide the grant-date value or accounting expense associated with the proposed equity awards.
Material changes versus the prior comparable period
The filing reports changes in executive leadership and compensation arrangements but does not provide a prior-period financial comparison. Mr. Sheikh continued as Chief Executive Officer, and Mr. Papkoff became Chief Product Officer.
Outlook, risks, contingencies, and unusual items
- The equity awards were subject to approval by the board of directors or compensation committee, as applicable.
- Vesting is generally contingent on continued employment and may accelerate upon a change in control.
- The agreements contain customary termination provisions and indemnification agreements.
- The proposed options and RSUs may result in future share dilution and stock-based compensation expense; the filing does not quantify either impact.
- No specific business outlook or financial guidance was provided.
Investor verification checklist
- Verify approval, grant date, exercise price, vesting terms, and expiration of the 844,200 stock options.
- Verify approval and detailed vesting conditions for the 295,000 RSUs.
- Assess the potential dilution and future stock-based compensation expense from both awards.
- Review Exhibits 10.1 and 10.2 for termination, change-in-control, and other contractual provisions.
- Consult subsequent filings for any changes in executive roles, compensation, or equity awards.